These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


459 related items for PubMed ID: 23647076

  • 1. Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma.
    Lin CY, Chen ST, Jeng YM, Yeh CC, Chou HY, Deng YT, Chang CC, Kuo MY.
    J Oral Pathol Med; 2011 Oct; 40(9):699-705. PubMed ID: 23647076
    [Abstract] [Full Text] [Related]

  • 2. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L, Wang Y, Xiao M, Lin Y, Yu L.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [Abstract] [Full Text] [Related]

  • 3. ANGPTL4 regulates the metastatic potential of oral squamous cell carcinoma.
    Tanaka J, Irié T, Yamamoto G, Yasuhara R, Isobe T, Hokazono C, Tachikawa T, Kohno Y, Mishima K.
    J Oral Pathol Med; 2015 Feb; 44(2):126-33. PubMed ID: 25060575
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
    Hwang YS, Ahn SY, Moon S, Zheng Z, Cha IH, Kim J, Zhang X.
    Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
    [Abstract] [Full Text] [Related]

  • 5. High expression of Naa10p associates with lymph node metastasis and predicts favorable prognosis of oral squamous cell carcinoma.
    Zeng Y, Zheng J, Zhao J, Jia PR, Yang Y, Yang GJ, Ma JF, Gu YQ, Xu J.
    Tumour Biol; 2016 May; 37(5):6719-28. PubMed ID: 26662107
    [Abstract] [Full Text] [Related]

  • 6. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
    Zhang H, Zhang J, Nan X, Li X, Qu J, Hong Y, Sun L, Chen Y, Li T.
    Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
    [Abstract] [Full Text] [Related]

  • 7. The chemokine receptor-CXCR2 plays a critical role in the invasion and metastases of oral squamous cell carcinoma in vitro and in vivo.
    Qian Y, Wang Y, Li DS, Zhu YX, Lu ZW, Ji QH, Yang G.
    J Oral Pathol Med; 2014 Oct; 43(9):658-66. PubMed ID: 24953191
    [Abstract] [Full Text] [Related]

  • 8. Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.
    Clauditz TS, Wang CJ, Gontarewicz A, Blessmann M, Tennstedt P, Borgmann K, Tribius S, Sauter G, Dalchow C, Knecht R, Münscher A, Wilczak W.
    J Oral Pathol Med; 2013 Feb; 42(2):125-32. PubMed ID: 22643116
    [Abstract] [Full Text] [Related]

  • 9. circIGHG-Induced Epithelial-to-Mesenchymal Transition Promotes Oral Squamous Cell Carcinoma Progression via miR-142-5p/IGF2BP3 Signaling.
    Liu J, Jiang X, Zou A, Mai Z, Huang Z, Sun L, Zhao J.
    Cancer Res; 2021 Jan 15; 81(2):344-355. PubMed ID: 33203701
    [Abstract] [Full Text] [Related]

  • 10. Axl is a prognostic marker in oral squamous cell carcinoma.
    Lee CH, Yen CY, Liu SY, Chen CK, Chiang CF, Shiah SG, Chen PH, Shieh YS.
    Ann Surg Oncol; 2012 Jul 15; 19 Suppl 3():S500-8. PubMed ID: 21842265
    [Abstract] [Full Text] [Related]

  • 11. Contactin 1 (CNTN1) expression associates with regional lymph node metastasis and is a novel predictor of prognosis in patients with oral squamous cell carcinoma.
    Wu HM, Cao W, Ye D, Ren GX, Wu YN, Guo W.
    Mol Med Rep; 2012 Aug 15; 6(2):265-70. PubMed ID: 22580838
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma.
    Lin LH, Lin JS, Yang CC, Cheng HW, Chang KW, Liu CJ.
    Int J Mol Sci; 2020 Mar 29; 21(7):. PubMed ID: 32235327
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of vascular endothelial growth factors A and C in oral squamous cell carcinoma.
    Yanase M, Kato K, Yoshizawa K, Noguchi N, Kitahara H, Nakamura H.
    J Oral Pathol Med; 2014 Aug 29; 43(7):514-20. PubMed ID: 24762199
    [Abstract] [Full Text] [Related]

  • 14. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
    Fang CY, Liew PL, Chen CL, Lin YH, Fang CL, Chen WY.
    Anticancer Res; 2017 Apr 29; 37(4):1891-1899. PubMed ID: 28373457
    [Abstract] [Full Text] [Related]

  • 15. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
    Chu W, Song X, Yang X, Ma L, Zhu J, He M, Wang Z, Wu Y.
    PLoS One; 2014 Apr 29; 9(7):e101931. PubMed ID: 24999732
    [Abstract] [Full Text] [Related]

  • 16. Functional invadopodia formation through stabilization of the PDPN transcript by IMP-3 and cancer-stromal crosstalk for PDPN expression.
    Hwang YS, Xianglan Z, Park KK, Chung WY.
    Carcinogenesis; 2012 Nov 29; 33(11):2135-46. PubMed ID: 22859271
    [Abstract] [Full Text] [Related]

  • 17. Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinoma.
    Kim SA, Lee KH, Lee DH, Lee JK, Lim SC, Joo YE, Chung IJ, Noh MG, Yoon TM.
    Int J Oncol; 2019 Aug 29; 55(2):513-526. PubMed ID: 31268163
    [Abstract] [Full Text] [Related]

  • 18. Knockdown of IFI27 inhibits cell proliferation and invasion in oral squamous cell carcinoma.
    Wang H, Qiu X, Lin S, Chen X, Wang T, Liao T.
    World J Surg Oncol; 2018 Mar 27; 16(1):64. PubMed ID: 29580248
    [Abstract] [Full Text] [Related]

  • 19. Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells.
    Dai J, Wei W.
    Arch Oral Biol; 2017 Nov 27; 83():40-46. PubMed ID: 28697409
    [Abstract] [Full Text] [Related]

  • 20. Expression of Gα12 predicts progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Cheng SJ, Liu YC, Cheng SL, Lee JJ, Chen HM, Chang HH, Kok SH, Kuo MY, Chiang CP.
    J Oral Pathol Med; 2013 Aug 27; 42(7):565-9. PubMed ID: 23438080
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.